The Indian government has extended the customs duty exemption for Remdesivir injections, the active pharmaceutical ingredient (API) for Remdesivir, and Beta Cyclodextrin (SBEBCD) used in its manufacture. This exemption applies to imports into India and is valid until 31st October 2021. The exemption is granted under specific conditions, including adherence to the Customs (Import of Goods at Concessional Rate of Duty) Rules, 2017 for SBEBCD.
GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(DEPARTMENT OF REVENUE)
Notification No. 27/2021-Customs
New Delhi, the 20thApril, 2021
G.S.R. (E).- In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, on being sat
Daily Limit Reached
You have reached your daily limit of 2 Free Notice & Circular
Subscribe to
CCI PRO
for unlimited access
Why Upgrade to
CCI PRO?
-
No Ads
-
WhatsApp Community
-
Daily E-Newsletter
-
Unlimited Notice & Circular Access
-
Profile Visitors
-
Link Social Profiles
-
Featured Job Posts
-
Pro Badge
-
Expert GST Guidance
-
Unlimited Forum Replies
-
Download Content in PDF
1 Year PLAN
1999
(Excl. of GST ₹359)
BEST VALUE
2 Years PLAN
3499
(Excl. of GST ₹629)
3 Months PLAN
999
(Excl. of GST ₹179)
View all CCI PRO benfits
Already a PRO member?
Login here
for an ad-free experience.
FAQ :
The exemption covers Remdesivir injections, Remdesivir Active Pharmaceutical Ingredients (API), and Beta Cyclodextrin (SBEBCD) when used in the manufacture of Remdesivir.
This notification remains in force up to and including 31st October 2021.
The exemption is issued by the Central Government of India, Ministry of Finance (Department of Revenue).
Yes, for Beta Cyclodextrin (SBEBCD) used in the manufacture of Remdesivir, the importer must follow the procedure set out in the Customs (Import of Goods at Concessional Rate of Duty) Rules, 2017.
Guest
Notification No : 27/2021-CustomsPublished in Custom
Source : https://www.cbic.gov.in/resources//htdocs-cbec/customs/cs-act/notifications/notfns-2021/cs-tarr2021/cs27-2021.pdf